Navigation Links


Helix Biopharma to Present L-DOS47 Lung Cancer Research Findings at the Fourth International Conference on Tumor Microenvironment in Florence, Italy

- Helix BioPharma Corp. (TSX: HBP /Frankfurt: WKN918864) AURORA, ON, March 5 /CNW/Dr. Heman Chao, Vice President of Researchat Helix BioPharma Corp., a developer of novel cancer therapeutics,will be presenting a scientific poster at the Fourth InternationalConference on Tumor Microenvironment, which runs from March 6th to10th in Florence, Italy. The conference, hosted by the...

Replidyne Phase II Pediatric Trial Meets Primary Objective

LOUISVILLE, Colo., March 06, 2007 /PRNewswire-FirstCall/ --Replidyne, Inc. announced today that it has completed its Phase IIclinical trial using faropenem medoxomil (faropenem) in pediatricpatients with acute otitis media (AOM), a common infection of themiddle ear. Initial analyses of the study results show that it metits primary objective to show that faropenem was effective ineradicatin...

DVT Awareness Survey Findings: Heart and Respiratory Patients

WASHINGTON, March 06, 2007 /PRNewswire/ -- Up to two millionAmericans are affected each year by DVT, with up to 600,000hospitalized. Its primary complication, pulmonary embolism (PE),claims up to 300,000 lives annually -- more than breast cancer andAIDS combined. People who suffer from cardiovascular disease may beat increased risk for DVT, because these factors also heighten thelikelihood...

Pozen Announces Positive Outcome for PA 325

Chapel Hill, N.C., March 6, 2007-Pozen Inc. (NASDAQ: POZN),today announced top-line results of its "Safer Aspirin" PA 325proof-of-concept study conducted during the fourth quarter of 2006.PA 325 is a patented formulation of 325mg of aspirin surrounded bya 20mg coating of an immediate release formulation of a proton pumpinhibitor. The PA 325, 28 day study, involved two groups of 40 subject...

Advanced Magnetics Announces Presentation of Ferumoxytol Data at the National Kidney Foundation 2007 Spring Clinical Meetings

CAMBRIDGE, Mass., March 06, 2007 /PRNewswire-FirstCall/ --Advanced Magnetics today announced that data from three completedPhase III multi- center clinical studies of ferumoxytol as anintravenous iron replacement therapeutic will be presented duringthe National Kidney Foundation (NKF) 2007 Spring Clinical Meetingstaking place April 10th through 14th in Orlando, Florida. Twoposters containi...

POZEN Announces Positive Outcome for PA 325 Proof of Concept Study

CHAPEL HILL, N.C.--(BUSINESS WIRE)--Mar 6, 2007 - POZEN Inc.(NASDAQ: POZN), today announced top-line results of its "SaferAspirin" PA 325 proof-of-concept study conducted during the fourthquarter of 2006. PA 325 is a patented formulation of 325mg ofaspirin surrounded by a 20mg coating of an immediate releaseformulation of a proton pump inhibitor. The PA 325, 28 day study, involved two group...

Nventa Announces Presentation of Positive HspE7 Data from NCI-Sponsored Clinical Trial in Cervical Dysplasia

- 78 Percent of Patients Showed Complete Response or Reduction ofLesion Size by More than Fifty Percent - SAN DIEGO, CA, March 05, 2007 /PRNewswire-FirstCall/ - NventaBiopharmaceuticals Corporation today announced the presentation ofpositive results from a clinical trial examining the safety andefficacy of pilot process HspE7, an investigational therapeuticvaccine for human papillomavirus (...

AOP Orphan Pharmaceuticals and Lantibio Announce Positive Phase II Study with Novel Cystic Fibrosis Therapy

VIENNA, Austria and CHAPEL HILL, N.C., US, March 06, 2007/PRNewswire/ -- AOP Orphan Pharmaceuticals AG ("AOP Orphan") andLantibio, Inc. ("Lantibio") today announced positive final resultsfrom their placebo controlled, double-blinded Phase II clinicalstudy of Moli1901, an experimental compound to treat cysticfibrosis ("CF"). Moli1901 is being developed by AOP Orphan inEurope under a licensi...

Advanced Cell Technology's Ability to Rescue Vision in Blind Rats Noted in Scientific American

ALAMEDA, Calif.--(BUSINESS WIRE)--Mar 5, 2007 - Advanced CellTechnology, Inc.'s (OTCBB: ACTC) ability to rescue vision in blindrats was noted in Scientific American's March 2007 issue as thelead story of its News Scan section. The full text of the article,which notes Advanced Cell's ability to "coax embryonic stem cellsto turn into transplantable retinal pigment epithelial (RPE)tissue," is...

Accentia Biopharmaceuticals Scientific Presentations Demonstrate Increasing Acceptance of Fungal Etiology of Chronic Sinusitis at the Annual Meeting of the American Academy of Allergy, Asthma, and Immunology

TAMPA, Fla.--(BUSINESS WIRE)--Mar 7, 2007 - AccentiaBiopharmaceuticals, Inc. (NASDAQ: ABPI), presented three posters atthe Annual Meeting of the American Academy of Allergy, Asthma, andImmunology from February 23 - 27, 2007 in San Diego, CA. Theposters discussed findings from a survey of 202 otolaryngologists(ENTs) and allergists in the U.S., U.K., France, and Germany on theburden of chroni...
[next]
(Date:2/13/2019)... ... February 13, 2019 , ... Following the longest federal ... the American Academy of Sleep Medicine (AASM) is warning that such shutdowns exacerbate ... and Transportation Security Administration (TSA) officers. , “Even in typical circumstances, safety may ...
(Date:2/13/2019)... FARMINGTON, Conn. (PRWEB) , ... February 13, 2019 , ... ... Points Technology LLC has been issued a Federal Information Security Management Act (FISMA) High ... Quality Tool. This validation of a secure environment is mandatory for the VA because ...
(Date:2/13/2019)... ... February 13, 2019 , ... American Vision ... in the nation, announced a new addition to their growing list of ophthalmology ... created within a multi-specialty ophthalmology practice. , Dr. Zachary Berbos, MD, ...
(Date:2/13/2019)... , ... February 13, 2019 , ... Surgery that moves ... and safe treatment for obstructive sleep apnea (OSA), resulting in benefits that include improved ... according to a new study. , MMA should be regarded as the preferred treatment ...
(Date:2/13/2019)... SANTA MONICA, Calif. (PRWEB) , ... February 13, ... ... Surgeon of Southern California has joined the esteemed Haute Beauty network. , ... is privileged to present Dr. Christie as a leading Aesthetic surgeon and our ...
Breaking Medicine News(10 mins):
... Wrap® Economy Universal Cervical ... with synthtic white stockinette ... for flexion or extension. ... air dry. 3"H.,Universal size ...
... perfect for use for lightweight padding. It ... used to line braces, prosthetics, orthotics and ... and vibration and conforms to all body ... It is a 2mm thick gel sheet ...
... patient need and comfort in mind, ... of products effectively address a variety ... frame attachment provides optimal post-operative support, ... superior support for patient maintenance and ...
... the therapeutic benefits of controlled compression to minimize ... ,The versatile cuff design enables it to be ... area. A support bar is incorporated into the ... easily removed if desired.,All Cryo/Cuffs can be ordered ...
Medicine Products:
(Date:2/13/2019)... OGDEN, Utah (PRWEB) , ... February 13, 2019 , ... ... Modified Music to Reduce Auditory Hypersensitivity in Children appears in Vol 11, No ... University and Alex Doman founder of Advanced Brain Technologies .     ...
(Date:2/13/2019)... , ... February 13, 2019 , ... ... , Kevin brings extensive experience in the medical device field to Boulder iQ. ... and quality services, specializing in the medical device and in-vitro diagnostic (IVD) ...
(Date:2/13/2019)... (PRWEB) , ... February 13, 2019 , ... ... a growth investment from healthcare leaders Intermountain Healthcare and Trinity Health. This round ... both providers and demonstrates their respective ongoing commitments to healthcare innovation, including the ...
Breaking Medicine Technology: